AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Public ClinicalTrials.gov record NCT07368959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ASTRA: A Phase 3 Multi-center, Randomized, Double-Masked, Prospective Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-3)
Study identification
- NCT ID
- NCT07368959
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Aurion Biotech
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Combination Product: AURN001 + Y-27632 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 18, 2026
- Primary completion
- May 31, 2027
- Completion
- Dec 31, 2027
- Last update posted
- Apr 7, 2026
2026 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 2 | Mesa | Arizona | 85206 | Recruiting |
| Investigational Site 6 | Little Rock | Arkansas | 72205 | Recruiting |
| Investigational Site 9 | Fort Collins | Colorado | 80528 | Recruiting |
| Investigational Site 7 | Atlanta | Georgia | 30339 | Recruiting |
| Investigational Site 4 | Kansas City | Missouri | 64154 | Recruiting |
| Investigational Site 11 | Leland | North Carolina | 28451 | Recruiting |
| Investigational Site 5 | Winston-Salem | North Carolina | 27157 | Recruiting |
| Investigational Site 3 | Cynwyd | Pennsylvania | 19004 | Recruiting |
| Investigational Site 10 | Plymouth Meeting | Pennsylvania | 19462 | Recruiting |
| Investigational Site 12 | Ladson | South Carolina | 29456 | Recruiting |
| Investigational Site 8 | San Antonio | Texas | 78209 | Recruiting |
| Investigational Site 1 | Spring | Texas | 77388 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07368959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07368959 live on ClinicalTrials.gov.